Urologia Internationalis
Case Report
Bladder Outlet Obstruction by a Lymphocele following Kidney TransplantationKatz R.a · Landau E.H.a · Pikarsky A.J.b · Eid A.baDepartments of Urology and Surgery, and bTransplantation Unit, Hadassah Medical Center, Hebrew University, Jerusalem, Israel
Ran Katz, MD, Department of Urology, Hadassah Ein Kerem Hospital, PO Box 12000, Jerusalem 91120 (Israel), Tel. +972 2 6776874, Fax +972 2 5861585, E-Mail rank@cc.huji.ac.il |
|
Abstract
Lymphocele is a well-known complication of kidney transplantation. Patients usually present with deteriorating renal function, hydronephrosis, a nontender lower abdominal mass or ipsilateral leg edema. Urinary retention, however, is an unusual presentation of lymphocele. We herein report a case of a female patient who developed chronic urinary retention due to a pelvic lymphocele after kidney transplantation.
© 1997 S. Karger AG, Basel
Related Articles:
Article / Publication Details
Received: November 20, 1996
Accepted: May 21, 1997
Published online: February 04, 2010
Issue release date: 1997
Number of Print Pages: 2
Number of Figures: 0
Number of Tables: 0
ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)
For additional information: https://www.karger.com/UIN
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
